Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

January 11, 2017 - 6:53 a.m.
European Commission Grants Marketing Authorization for Gilead’s Vemlidy® (Tenofovir Alafenamide, TAF) for the Treatment of Chronic Hepatitis B Virus InfectionPrinter Friendly Version 
January 10, 2017 - 9:01 a.m.
Gilead Awards More Than $22 Million in Grants to Support HIV Cure ResearchPrinter Friendly Version 

Upcoming Events

Tuesday, February 7, 2017 4:30 p.m. ET
Fourth Quarter 2016 Gilead Sciences Earnings Conference Call
LocationFoster City, CA
Monday, February 13, 2017 through Friday, February 17, 2017
Conference on Retroviruses and Opportunistic Infections (CROI)
LocationSeattle, WA

Most Viewed Links

Updated 01/17/17
1.SEC Filings
2.Gilead Sciences at 35th Annual J.P. Morgan Healthcare Conference
4.Annual Reports
5.Audio Archives
* Data collected 01/09/17 - 01/16/17

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
NASDAQ (US Dollar)
 Stock is Down 0.08 (0.11%)
Data as of 01/18/17 12:54 p.m. ET
Minimum 20 minute delay
Refresh Quote
Recent Webcasts
Gilead Sciences at 35th Annual J.P. Morgan Healthcare Conference

January 09, 2017 10:30 a.m. PT
Piper Jaffray 28th Annual Healthcare Conference

November 29, 2016 8:00 a.m. ET